Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Genpact Ltd has a consensus price target of $45.33 based on the ratings of 9 analysts. The high is $55 issued by Mizuho on February 10, 2025. The low is $33 issued by Citigroup on April 22, 2024. The 3 most-recent analyst ratings were released by Baird, Needham, and Mizuho on May 8, 2025, May 8, 2025, and February 10, 2025, respectively. With an average price target of $51.67 between Baird, Needham, and Mizuho, there's an implied 16.26% upside for Genpact Ltd from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
05/08/2025 | Buy Now | 12.51% | Baird | David Koning78% | $56 → $50 | Maintains | Neutral | Get Alert |
05/08/2025 | Buy Now | 12.51% | Needham | Mayank Tandon68% | $55 → $50 | Maintains | Buy | Get Alert |
02/10/2025 | Buy Now | 23.76% | Mizuho | Dan Dolev65% | $45 → $55 | Maintains | Neutral | Get Alert |
02/07/2025 | Buy Now | 46.26% | Needham | Mayank Tandon68% | $55 → $65 | Maintains | Buy | Get Alert |
01/21/2025 | Buy Now | 23.76% | Jefferies | Surinder Thind57% | $44 → $55 | Upgrade | Hold → Buy | Get Alert |
11/11/2024 | Buy Now | 23.76% | Needham | Mayank Tandon68% | $42 → $55 | Maintains | Buy | Get Alert |
11/08/2024 | Buy Now | 1.26% | TD Cowen | Bryan Bergin62% | $40 → $45 | Maintains | Hold | Get Alert |
11/08/2024 | Buy Now | 8.01% | Baird | David Koning78% | $44 → $48 | Maintains | Neutral | Get Alert |
10/09/2024 | Buy Now | -0.99% | Baird | David Koning78% | $38 → $44 | Maintains | Neutral | Get Alert |
09/09/2024 | Buy Now | -9.99% | Jefferies | Surinder Thind57% | $35 → $40 | Maintains | Hold | Get Alert |
09/06/2024 | Buy Now | -3.24% | JP Morgan | Tien-Tsin Huang64% | $35 → $43 | Maintains | Neutral | Get Alert |
08/12/2024 | Buy Now | -5.49% | BMO Capital | Keith Bachman82% | $38 → $42 | Maintains | Market Perform | Get Alert |
08/09/2024 | Buy Now | -18.99% | TD Cowen | Bryan Bergin62% | $35 → $36 | Maintains | Hold | Get Alert |
08/09/2024 | Buy Now | -5.49% | Needham | Mayank Tandon68% | $40 → $42 | Maintains | Buy | Get Alert |
07/17/2024 | Buy Now | -9.99% | JP Morgan | Tien-Tsin Huang64% | $43 → $40 | Upgrade | Underweight → Neutral | Get Alert |
05/10/2024 | Buy Now | -9.99% | Needham | Mayank Tandon68% | $40 → $40 | Reiterates | Buy → Buy | Get Alert |
05/10/2024 | Buy Now | -21.24% | Wedbush | Moshe Katri72% | $35 → $35 | Reiterates | Neutral → Neutral | Get Alert |
05/10/2024 | Buy Now | -14.49% | BMO Capital | Keith Bachman82% | $39 → $38 | Maintains | Market Perform | Get Alert |
04/22/2024 | Buy Now | -25.74% | Citigroup | Ashwin Shirvaikar73% | $36 → $33 | Maintains | Neutral | Get Alert |
02/09/2024 | Buy Now | -3.24% | JP Morgan | Tien-Tsin Huang64% | $42 → $43 | Maintains | Underweight | Get Alert |
02/09/2024 | Buy Now | -9.99% | Needham | Mayank Tandon68% | → $40 | Reiterates | Buy → Buy | Get Alert |
01/30/2024 | Buy Now | -9.99% | Mizuho | Dan Dolev65% | → $40 | Initiates | → Neutral | Get Alert |
01/17/2024 | Buy Now | -18.99% | Citigroup | Ashwin Shirvaikar73% | $35 → $36 | Maintains | Neutral | Get Alert |
12/15/2023 | Buy Now | -14.49% | Baird | David Koning78% | → $38 | Downgrade | Outperform → Neutral | Get Alert |
11/09/2023 | Buy Now | -9.99% | Needham | Mayank Tandon68% | $50 → $40 | Maintains | Buy | Get Alert |
08/22/2023 | Buy Now | -9.99% | JP Morgan | Tien-Tsin Huang64% | → $40 | Downgrade | Neutral → Underweight | Get Alert |
08/11/2023 | Buy Now | 12.51% | Needham | Mayank Tandon68% | $56 → $50 | Maintains | Buy | Get Alert |
08/10/2023 | Buy Now | -9.99% | JP Morgan | Tien-Tsin Huang64% | $46 → $40 | Maintains | Neutral | Get Alert |
08/10/2023 | Buy Now | 1.26% | Wedbush | Moshe Katri72% | → $45 | Reiterates | Neutral → Neutral | Get Alert |
08/10/2023 | Buy Now | -7.74% | BMO Capital | Keith Bachman82% | $46 → $41 | Maintains | Market Perform | Get Alert |
07/18/2023 | Buy Now | -5.49% | Citigroup | Ashwin Shirvaikar73% | $46 → $42 | Downgrade | Buy → Neutral | Get Alert |
06/07/2023 | Buy Now | 1.26% | Wedbush | Moshe Katri72% | → $45 | Reiterates | Neutral → Neutral | Get Alert |
05/15/2023 | Buy Now | -7.74% | Jefferies | Surinder Thind57% | $47 → $41 | Maintains | Hold | Get Alert |
05/11/2023 | Buy Now | 3.51% | BMO Capital | Keith Bachman82% | $53 → $46 | Maintains | Market Perform | Get Alert |
05/11/2023 | Buy Now | -0.99% | TD Cowen | Bryan Bergin62% | $48 → $44 | Maintains | Market Perform | Get Alert |
05/11/2023 | Buy Now | 8.01% | Baird | David Koning78% | $54 → $48 | Maintains | Outperform | Get Alert |
05/11/2023 | Buy Now | 26.01% | Needham | Mayank Tandon68% | → $56 | Reiterates | Buy → Buy | Get Alert |
05/11/2023 | Buy Now | 3.51% | Citigroup | Ashwin Shirvaikar73% | $54 → $46 | Maintains | Buy | Get Alert |
02/13/2023 | Buy Now | 21.51% | Citigroup | Ashwin Shirvaikar73% | $52 → $54 | Maintains | Buy | Get Alert |
02/10/2023 | Buy Now | 26.01% | Needham | Mayank Tandon68% | → $56 | Reiterates | → Buy | Get Alert |
02/08/2023 | Buy Now | 19.26% | BMO Capital | Keith Bachman82% | $51 → $53 | Maintains | Market Perform | Get Alert |
12/15/2022 | Buy Now | 12.51% | JP Morgan | Tien-Tsin Huang64% | $55 → $50 | Downgrade | Overweight → Neutral | Get Alert |
11/10/2022 | Buy Now | 14.76% | BMO Capital | Keith Bachman82% | $57 → $51 | Maintains | Market Perform | Get Alert |
11/10/2022 | Buy Now | 17.01% | Citigroup | Ashwin Shirvaikar73% | $56 → $52 | Maintains | Buy | Get Alert |
10/14/2022 | Buy Now | 23.76% | JP Morgan | Tien-Tsin Huang64% | $62 → $55 | Maintains | Overweight | Get Alert |
07/20/2022 | Buy Now | 17.01% | Citigroup | Ashwin Shirvaikar73% | $55 → $52 | Maintains | Buy | Get Alert |
The latest price target for Genpact (NYSE:G) was reported by Baird on May 8, 2025. The analyst firm set a price target for $50.00 expecting G to rise to within 12 months (a possible 12.51% upside). 15 analyst firms have reported ratings in the last year.
The latest analyst rating for Genpact (NYSE:G) was provided by Baird, and Genpact maintained their neutral rating.
The last upgrade for Genpact Ltd happened on January 21, 2025 when Jefferies raised their price target to $55. Jefferies previously had a hold for Genpact Ltd.
The last downgrade for Genpact Ltd happened on December 15, 2023 when Baird changed their price target from N/A to $38 for Genpact Ltd.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Genpact, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Genpact was filed on May 8, 2025 so you should expect the next rating to be made available sometime around May 8, 2026.
While ratings are subjective and will change, the latest Genpact (G) rating was a maintained with a price target of $56.00 to $50.00. The current price Genpact (G) is trading at is $44.44, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.